Dr. Shaheen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Rd
Ste 2222
San Antonio, TX 78229Phone+1 210-450-1143Fax+1 210-450-0407
Education & Training
Damascus University Faculty of MedicineClass of 1996
Certifications & Licensure
NM State Medical License 2008 - 2027
TX State Medical License 2022 - 2025
AZ State Medical License 2016 - 2024
IN State Medical License 2000 - 2011
IL State Medical License 1997 - 2005
Clinical Trials
- A Study of APG-115 in Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors Start of enrollment: 2018 Aug 29
Roles: Principal Investigator, Contact
- An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) Start of enrollment: 2019 Jul 18
Roles: Contact
Publications & Presentations
PubMed
- 220 citationsNeoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost
The New England Journal of Medicine. 2023-03-02 - 31 citationsTilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.Cara Haymaker, Daniel H. Johnson, Ravi Murthy, Salah-Eddine Bentebibel, Marc Uemura
Cancer Discovery. 2021-01-01 - 30 citationsA phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors.Michael A. Carducci, Montaser Shaheen, Ben Markman, Sara A. Hurvitz, Daruka Mahadevan
Investigational New Drugs. 2018-07-07
Journal Articles
- Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase 1b StudyKaren Kelly, Montaser Shaheen, Shadia Jalal, Daruka Mahadevan, Clinical Cancer Research
Press Mentions
OncoSec Medical Hosting SITC Key Opinion Leader Webinar on Updated Data from the KEYNOTE-695 StudyNovember 2nd, 2021- Live from ASCO 2023 | for the Third Consecutive Year, Ascentage Pharma Releases Promising Results of Alrizomadlin plus Pembrolizumab in Patients with Cutaneous Melanoma That Failed Immuno-Oncologic (IO) TherapiesJune 6th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
